搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Burkholderia cenocepacia 50S ribosomal protein L15 (rplO) CSB-YP370165BPO
CSB-EP370165BPO
CSB-BP370165BPO
CSB-MP370165BPO
CSB-EP370165BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 50S ribosomal protein L17 (rplQ) CSB-YP370166BPO
CSB-EP370166BPO
CSB-BP370166BPO
CSB-MP370166BPO
CSB-EP370166BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 3-dehydroquinate synthase (aroB) CSB-YP370167BPO
CSB-EP370167BPO
CSB-BP370167BPO
CSB-MP370167BPO
CSB-EP370167BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP370168BPO
CSB-EP370168BPO
CSB-BP370168BPO
CSB-MP370168BPO
CSB-EP370168BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Phosphoribosyl-ATP pyrophosphatase (hisE) CSB-YP370169BPO
CSB-EP370169BPO
CSB-BP370169BPO
CSB-MP370169BPO
CSB-EP370169BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Sec-independent protein translocase protein TatB (tatB), partial CSB-YP370170BPO
CSB-EP370170BPO
CSB-BP370170BPO
CSB-MP370170BPO
CSB-EP370170BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Anthranilate phosphoribosyltransferase (trpD) CSB-YP370171BPO
CSB-EP370171BPO
CSB-BP370171BPO
CSB-MP370171BPO
CSB-EP370171BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP370172BPO
CSB-EP370172BPO
CSB-BP370172BPO
CSB-MP370172BPO
CSB-EP370172BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP370173BPO
CSB-EP370173BPO
CSB-BP370173BPO
CSB-MP370173BPO
CSB-EP370173BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia UPF0289 protein Bcen2424_0574 (Bcen2424_0574) CSB-YP370174BPO
CSB-EP370174BPO
CSB-BP370174BPO
CSB-MP370174BPO
CSB-EP370174BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia RNA pyrophosphohydrolase (rppH) CSB-YP370175BPO
CSB-EP370175BPO
CSB-BP370175BPO
CSB-MP370175BPO
CSB-EP370175BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Arabinose import ATP-binding protein AraG 1 (araG1), partial CSB-YP370176BPO
CSB-EP370176BPO
CSB-BP370176BPO
CSB-MP370176BPO
CSB-EP370176BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Gamma-glutamyl phosphate reductase (proA) CSB-YP370177BPO
CSB-EP370177BPO
CSB-BP370177BPO
CSB-MP370177BPO
CSB-EP370177BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP370178BPO
CSB-EP370178BPO
CSB-BP370178BPO
CSB-MP370178BPO
CSB-EP370178BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP370179BPO
CSB-EP370179BPO
CSB-BP370179BPO
CSB-MP370179BPO
CSB-EP370179BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP370180BPO
CSB-EP370180BPO
CSB-BP370180BPO
CSB-MP370180BPO
CSB-EP370180BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Chaperone protein DnaK (dnaK), partial CSB-YP370181BPO
CSB-EP370181BPO
CSB-BP370181BPO
CSB-MP370181BPO
CSB-EP370181BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP370182BPO
CSB-EP370182BPO
CSB-BP370182BPO
CSB-MP370182BPO
CSB-EP370182BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia D- (-)-3-hydroxybutyrate oligomer hydrolase, partial CSB-YP370183BPO
CSB-EP370183BPO
CSB-BP370183BPO
CSB-MP370183BPO
CSB-EP370183BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia cenocepacia Urease accessory protein UreG (ureG) CSB-YP370184BPO
CSB-EP370184BPO
CSB-BP370184BPO
CSB-MP370184BPO
CSB-EP370184BPO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>